Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China | Zendy

Xiaohui Zou | Zendy; Kang Chang | Zendy; Yeming Wang | Zendy; Mengxue Li | Zendy; Wang Zhang | Zendy; Chunlei Wang | Zendy; Binghuai Lu | Zendy; Zhujia Xiong | Zendy; Jiajing Han | Zendy; Yulin Zhang | Zendy; Jiankang Zhao | Zendy; Bin Cao | Zendy

Open Access

Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China

Author(s) -

Xiaohui Zou,

Kang Chang,

Yeming Wang,

Mengxue Li,

Wang Zhang,

Chunlei Wang,

Binghuai Lu,

Zhujia Xiong,

Jiajing Han,

Yulin Zhang,

Jiankang Zhao,

Bin Cao

Publication year - 2019

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2018.12.014

Subject(s) - virology , medicine , titer , covid-19 , virus , disease , infectious disease (medical specialty)

The Xpert Xpress Flu/RSV assay is released by FDA for rapid detection of influenza A (FluA), influenza B (FluB), and respiratory syncytial virus (RSV). This study aimed to evaluate its clinical performance in comparison to that of the RT-PCR assay cleared by China FDA (CFDA-PCR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research